Provided by Tiger Fintech (Singapore) Pte. Ltd.

NanoVibronix Inc

2.89
-0.8250-22.24%
Volume:161.31K
Turnover:490.60K
Market Cap:2.38M
PE:-0.21
High:3.71
Open:3.71
Low:2.83
Close:3.71
Loading ...

Company Profile

Company Name:
NanoVibronix Inc
Exchange:
NASDAQ
Establishment Date:
2003
Employees:
31
Office Location:
969 Pruitt Ave,Tyler,Texas,United States
Zip Code:
77569
Fax:
914 930 4199
Introduction:
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas.

Directors

Name
Position
Brian Murphy
Chief Executive Officer and Director
Christopher Fashek
Chairman of the Board
Harold Jacob
Chief Medical Officer and Director
Aurora Cassirer
Director
Maria Schroeder
Director
Martin Goldstein
Director
Michael Ferguson
Director
Thomas R. Mika
Director

Shareholders

Name
Position
Brian Murphy
Chief Executive Officer and Director
Stephen Brown
Chief Financial Officer
Harold Jacob
Chief Medical Officer and Director